Sponsors and Partners

Corporate Partners

Pharmaceutical Partners

Conflict of Interest Statement—Industry Partners

  • Corporate partners including industry do not shape OCRA’s agenda, research or advocacy.
  • In 2022, industry partners represented 6% of OCRA’s overall revenue.
  • No industry personnel serve on OCRA’s governing board (Board of Directors).
  • If an industry partner sponsors an OCRA program, grant or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input. 
  • Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.

Read OCRA’s full Conflict of Interest policy for Industry Partners.